KR20080108515A - 고혈압의 치료를 위한 레닌 억제제 - Google Patents

고혈압의 치료를 위한 레닌 억제제 Download PDF

Info

Publication number
KR20080108515A
KR20080108515A KR1020087024219A KR20087024219A KR20080108515A KR 20080108515 A KR20080108515 A KR 20080108515A KR 1020087024219 A KR1020087024219 A KR 1020087024219A KR 20087024219 A KR20087024219 A KR 20087024219A KR 20080108515 A KR20080108515 A KR 20080108515A
Authority
KR
South Korea
Prior art keywords
discontinuation
renin inhibitor
hypertension
blood pressure
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020087024219A
Other languages
English (en)
Korean (ko)
Inventor
앤드류 새틀린
Original Assignee
노파르티스 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38420678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20080108515(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 노파르티스 아게 filed Critical 노파르티스 아게
Publication of KR20080108515A publication Critical patent/KR20080108515A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020087024219A 2006-04-03 2007-03-30 고혈압의 치료를 위한 레닌 억제제 Withdrawn KR20080108515A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78884206P 2006-04-03 2006-04-03
US60/788,842 2006-04-03

Publications (1)

Publication Number Publication Date
KR20080108515A true KR20080108515A (ko) 2008-12-15

Family

ID=38420678

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087024219A Withdrawn KR20080108515A (ko) 2006-04-03 2007-03-30 고혈압의 치료를 위한 레닌 억제제

Country Status (20)

Country Link
US (1) US20090062395A1 (enExample)
EP (1) EP2004167A1 (enExample)
JP (1) JP2009532494A (enExample)
KR (1) KR20080108515A (enExample)
CN (1) CN101415413A (enExample)
AU (1) AU2007234917B2 (enExample)
BR (1) BRPI0710095A2 (enExample)
CA (1) CA2645260A1 (enExample)
CL (1) CL2007000912A1 (enExample)
IL (1) IL193905A0 (enExample)
MA (1) MA30387B1 (enExample)
MX (1) MX2008012729A (enExample)
NO (1) NO20084625L (enExample)
NZ (1) NZ571251A (enExample)
RU (1) RU2008143055A (enExample)
SG (1) SG170830A1 (enExample)
TN (1) TNSN08383A1 (enExample)
TW (1) TW200806283A (enExample)
WO (1) WO2007118023A1 (enExample)
ZA (1) ZA200807615B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009087116A1 (en) * 2008-01-11 2009-07-16 Novartis Ag Use of spp100 for the treatment of acute mi
CN102212012A (zh) * 2010-04-12 2011-10-12 上海源力生物技术有限公司 一种合成阿利克伦的中间体及其制备方法
EP2768971A1 (en) 2011-10-20 2014-08-27 Institut National de la Santé et de la Recherche Médicale (INSERM) Methods for the detection and the treatment of cardiac remodeling
EP3956021A4 (en) * 2019-04-18 2023-06-14 EyePoint Pharmaceuticals, Inc. METHOD OF TREATMENT OF HIGH BLOOD PRESSURE WITH ACTIVATORS OF TIE-2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5659065A (en) * 1994-04-18 1997-08-19 Novartis Corporation Alpha-aminoalkanoic acids and reduction products
US5606078A (en) * 1994-04-18 1997-02-25 Ciba-Geigy Corporation 3,5-Disubstituted tetrahydrofuran-2-ones
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
AU2003250858A1 (en) * 2002-06-28 2004-01-19 Novartis Ag Use of organic compounds
WO2004100871A2 (en) * 2003-05-09 2004-11-25 Pharmacia Corporation Combination of an aldosterone receptor antagonist and a renin inhibitor
US20050209141A1 (en) * 2003-10-17 2005-09-22 Silver Randi B Mast cell-derived renin
MY144477A (en) * 2004-03-17 2011-09-30 Novartis Ag Galenic formulations of organic compounds
CA2581927C (en) * 2004-09-27 2013-04-09 Pantarhei Bioscience B.V. Treatment or prevention of unscheduled bleeding in women on progestogen containing medication

Also Published As

Publication number Publication date
AU2007234917B2 (en) 2011-05-12
WO2007118023A1 (en) 2007-10-18
IL193905A0 (en) 2009-08-03
JP2009532494A (ja) 2009-09-10
TNSN08383A1 (en) 2009-12-29
TW200806283A (en) 2008-02-01
RU2008143055A (ru) 2010-05-10
SG170830A1 (en) 2011-05-30
ZA200807615B (en) 2009-10-28
MA30387B1 (fr) 2009-05-04
US20090062395A1 (en) 2009-03-05
AU2007234917A1 (en) 2007-10-18
EP2004167A1 (en) 2008-12-24
NZ571251A (en) 2011-12-22
MX2008012729A (es) 2008-10-14
CL2007000912A1 (es) 2008-03-14
NO20084625L (no) 2008-11-03
CN101415413A (zh) 2009-04-22
BRPI0710095A2 (pt) 2011-08-02
CA2645260A1 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
AU2010200833B2 (en) Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure
KR20070102544A (ko) 유기 화합물의 조합물
US20090247582A1 (en) Methods of treating atherosclerosis
EP3013327B1 (en) Pharmaceutical capsule composite formulation comprising tadalafil and tamsulosin
MD3684344T2 (ro) Comprimate de deferipronă cu eliberare întârziată și metode de utilizare a acestora
AU2014350135A1 (en) Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
AU2007234917B2 (en) Renin inhibitors for the treatment of hypertension
JPWO2008020651A1 (ja) Ｐ２ｘ４受容体アンタゴニスト
US20060159751A1 (en) Controlled release pharmaceutical compositions of carbidopa and levodopa
US20260137642A1 (en) Methods of treating patients having type 1 diabetes with eflornithine
KR20090090384A (ko) 비만 환자에서 고혈압의 예방 및 치료를 위한 레닌 억제제
WO2005016319A2 (en) Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning
US7199153B2 (en) Pharmaceutical composition comprising paracetamol and niflumic acid
US20100120921A1 (en) Renin inhibitors for treatment of hypertension in patients with high sodium diet
AU2011236117A1 (en) Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure
MXPA01007833A (es) Metodo para prevenir o reducir eventos cardiovasculares asociados con intervencion de la arteria coronaria.
KR20010101934A (ko) 관상혈관 시술과 관련된 심혈관 사건의 예방 및 감소 방법
HK1162923A (en) Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20081002

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid